Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-10 Purchase |
2023-04-11 5:40 pm |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
468,750 | $1.6 | $750,000 | 608,750 (Direct) |
View |
| 2022-12-08 Purchase |
2022-12-12 4:34 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
57,079 | $1.4195 | $81,023 | 306,868 (Indirect Direct) |
View |
| 2022-12-06 Purchase |
2022-12-08 4:55 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
24,874 | $1.3954 | $34,709 | 249,789 (Indirect Direct) |
View |
| 2022-12-02 Purchase |
2022-12-06 3:19 pm |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner |
2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) |
View |
| 2022-12-02 Sale |
2022-12-06 3:19 pm |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB TomEqt Private AB 10% Owner |
2,855,847 | $1.235 | $3,526,971 | 2,855,847 (Indirect) |
View |
| 2022-12-05 Purchase |
2022-12-05 4:16 pm |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
35,000 | $1.3855 | $48,493 | 154,327 (Direct) |
View |
| 2022-12-01 Purchase |
2022-12-05 4:08 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
819 | $1.19 | $975 | 224,915 (Indirect Direct) |
View |
| 2022-11-29 Purchase |
2022-12-01 5:11 pm |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
67,228 | $1.1969 | $80,463 | 278,282 (Indirect Direct) |
View |
| 2022-11-16 Purchase |
2022-11-16 8:56 pm |
DiaMedica Therapeutics Inc. | DMAX | Pauls Dietrich John President and CEO |
20,000 | $1.21 | $24,200 | 55,804 (Direct) |
View |
| 2022-07-08 Purchase |
2022-07-21 1:06 pm |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB 10% Owner |
207,974 | $1.3266 | $275,898 | 2,855,827 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-01 Option Award |
2023-06-02 4:55 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Gruis Kirsten L Chief Medical Officer |
67,000 | $0 | 67,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:46 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
67,000 | $0 | 89,290 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:39 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
181,000 | $0 | 236,804 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:33 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
16,968 | $0 | 34,124 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:26 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
22,355 | $0 | 232,237 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:21 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
16,968 | $0 | 55,477 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:13 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director |
7,493 | $0 | 7,493 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 4:02 pm |
N/A 2033-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
16,968 | $0 | 358,966 (Direct) |
View |
| 2023-05-30 Option Award |
2023-05-30 6:18 pm |
N/A 2033-05-29 |
DiaMedica Therapeutics Inc. | DMAC | Kuntz Richard Director |
32,320 | $0 | 32,320 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-11 5:40 pm |
N/A 2033-04-09 |
DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer |
140,000 | $0 | 608,750 (Direct) |
View |
| 2023-03-01 Option Award |
2023-03-06 5:14 pm |
N/A 2033-02-28 |
DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director |
26,443 | $0 | 26,443 (Direct) |
View |
Ownership |
2023-03-06 5:06 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Lewis Tanya Director |
0 | $0 | 0 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 4:43 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
35,130 | $1.53 | 341,998 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 4:36 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director |
17,156 | $1.53 | 73,288 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 4:25 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
17,156 | $1.53 | 17,156 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-03 4:19 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
55,555 | $1.53 | 209,882 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 4:41 pm |
N/A 2032-09-12 |
DiaMedica Therapeutics Inc. | DMAC | Daves Julie VanOrsdel SVP Clinical Development Oper. |
140,000 | $0 | 140,000 (Direct) |
View |
Ownership |
2022-09-15 4:15 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Daves Julie VanOrsdel SVP Clinical Development Oper. |
0 | $0 | 0 (Direct) |
View |
Ownership |
2022-07-21 1:03 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Von Koch Thomas TomEnterprise AB 10% Owner |
0 | $0 | 2,647,873 (Indirect) |
View |
| 2022-06-01 Option Award |
2022-06-02 5:06 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pauls Dietrich John President and CEO |
177,000 | $0 | 212,804 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 5:02 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Kellen Scott CFO and Secretary |
60,000 | $0 | 82,290 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:58 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Burroughs Amy L. Director |
13,222 | $0 | 69,354 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:51 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Giuffre Randall Michael Director |
13,222 | $0 | 224,276 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:44 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Parsons James T. Director |
13,222 | $0 | 51,731 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:38 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Pilnik Richard D. Director |
18,510 | $0 | 137,837 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 4:34 pm |
N/A 2032-05-31 |
DiaMedica Therapeutics Inc. | DMAC | Semba Charles Pauling Director |
13,222 | $0 | 13,222 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 4:45 pm |
N/A 2032-02-01 |
DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer |
165,000 | $0 | 167,800 (Direct) |
View |
Ownership |
2022-02-02 4:37 pm |
N/A N/A |
DiaMedica Therapeutics Inc. | DMAC | Cundari Dominic R Chief Commercial Officer |
0 | $0 | 2,800 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:57 pm |
N/A 2032-01-02 |
DiaMedica Therapeutics Inc. | DMAC | Gruis Kirsten L Chief Medical Officer |
160,000 | $0 | 160,000 (Direct) |
View |